ACSS1 co-opts acetyl-CoA metabolism to drive DNA repair and undermine radiotherapy efficacy in breast cancer
Open Access
- 18 December 2025
- journal article
- research article
- Published by Springer Nature in Cell Death & Disease
- Vol. 17 (1)
Abstract
Breast cancer remains a leading cause of cancer-related mortality worldwide, with radiotherapy serving as a cornerstone of treatment. However, the development of radioresistance significantly compromises therapeutic efficacy and patient outcomes. Through integrative analysis of TCGA and GEO datasets combined with quantitative proteomics, we identified acetyl-CoA synthetase 1 (ACSS1) as a key driver of radioresistance in breast cancer. ACSS1 is aberrantly overexpressed in breast cancer and correlates with poor prognosis following radiotherapy. Functional studies revealed that overexpressed ACSS1 is able to enhance radioresistance both in vitro and in vivo. Mechanistically, ACSS1 amplifies the ionizing radiation (IR)-induced metabolic coupling of pyruvate with ROS for acetate synthesis, which fuels energy production and expands the nuclear acetyl-CoA pool, enabling histone acetylation at DNA damage sites. Such acetylation promotes chromatin relaxation at damage sites, facilitating the recruitment of homologous recombination (HR) repair machinery and ultimately leading to radioresistance. Our findings reveal that ACSS1 orchestrates acetyl-CoA-driven histone acetylation to enhance DNA repair efficiency, highlighting a metabolic-epigenetic crosstalk that sustains radioresistance in breast cancer. Targeting ACSS1 represents a promising therapeutic strategy to sensitize tumours to radiotherapy and improve clinical outcomes in breast cancer patients.Keywords
This publication has 50 references indexed in Scilit:
- ACSS1-dependent acetate utilization rewires mitochondrial metabolism to support AML and melanoma tumor growth and metastasisCell Reports, 2024
- Combining radiation and the ATR inhibitor berzosertib activates STING signaling and enhances immunotherapy via inhibiting SHP1 function in colorectal cancerCancer Communications, 2023
- The Role of Stereotactic Ablative Body Radiotherapy in Renal Cell CarcinomaEuropean Urology, 2022
- In-vitro 3D modelling for charged particle therapy – Uncertainties and opportunitiesAdvanced Drug Delivery Reviews, 2021
- Acetate Production from Glucose and Coupling to Mitochondrial Metabolism in MammalsCell, 2018
- Short‐Chain Fatty Acid Transporters: Role in Colonic HomeostasisComprehensive Physiology, 2018
- Nuclear Acetyl-CoA Production by ACLY Promotes Homologous RecombinationMolecular Cell, 2017
- PRMT5-Dependent Methylation of the TIP60 Coactivator RUVBL1 Is a Key Regulator of Homologous RecombinationMolecular Cell, 2017
- Stratification of Hepatocellular Carcinoma Patients Based on Acetate UtilizationCell Reports, 2015
- Acetyl-CoA Synthetase 2 Promotes Acetate Utilization and Maintains Cancer Cell Growth under Metabolic StressCancer Cell, 2015